Milestone Pharmaceuticals (MIST) Non Operating Income (2021 - 2022)
Milestone Pharmaceuticals (MIST) posted Non Operating Income of $474000.0 for Q3 2022, up 200.0% on a QoQ basis from $158000.0 in Q2 2022, and up 887.5% year-over-year from $48000.0 in Q3 2021.
Milestone Pharmaceuticals (MIST) Non Operating Income (2021 - 2022) Analysis & Trends
Milestone Pharmaceuticals' Non Operating Income history runs 2 years deep, the most recent figure standing at $474000.0 for Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 474,000.00 |
| Jun 30, 2022 | 158,000.00 |
| Sep 30, 2021 | 48,000.00 |
| Jun 30, 2021 | 58,000.00 |